Clinical Trial Update: 1. SAFE-AI ONCO-TRACK: Multimodal GenAI for Early Detection of Minimal Residual Disease and Recurrence in Gastrointestinal Oncology

View source ↗

Summary

The SAFE-AI ONCO-TRACK study uses a multimodal generative AI approach to detect minimal residual disease and recurrence in rectal cancer and is currently not ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: Università Politecnica delle Marche | Conditions: Rectal Cancer | Status: NOT_YET_RECRUITING